Arbutus, Genevant expand COVID patent feud with Moderna with 5 international lawsuits
The companies claim that Moderna stepped on their lipid nanoparticle technology with its COVID vaccine Spikevax and RSV vaccine mRESVIA.
The companies claim that Moderna stepped on their lipid nanoparticle technology with its COVID vaccine Spikevax and RSV vaccine mRESVIA.
